QSQuantSignals Research/Studies
Try FST free

← All studies

FAIL

Do long options bought when implied vol is at or below realized vol beat buying them every month?

When a long option's implied vol is at or below the lower of its one-year and three-month realized vol, does buying it beat buying the same option on every monthly date, after costs?

Seven of the eight pre-registered tests failed. The one pass is T7, the 0.9x threshold on year-out at-the-money options: 241 trades from 33 monthly entries returned +0.844 per option against +0.241 for buying the same options every month, a difference of +0.603 with a bootstrap band of [+0.006, +1.103], and +0.907 on the 2022-2026 half. The pass is marginal: the observed difference is below the smallest difference the test was built to detect (+1.85), the median trade returned -1.0, and 55.2% of trades lost the whole premium. It is also flattered by the data end: every long-dated entry made in 2026 expires after the last close and is valued at zero, which is 19 of T7's 241 signal trades but 282 of its 1,561 baseline trades, and the long-dated entries of November and December 2025 are valued at zero for the same reason. On simple pooled means, dropping the 2026 trades lowers the difference from +0.709 to +0.617, and dropping the late-2025 ones too would lower it further; whether the bootstrap lower bound stays above zero without them is not known. The four primary tests at the tool's 1.0x threshold all failed, so the tool's 'cheap' verdict is not validated. T7 is published as the lead that the follow-up test on other names went on to test, not as an edge.

One of the eight pre-registered tests passed: T7, the 0.9x sensitivity test on year-out at-the-money options. The four primary tests at the tool's 1.0x threshold all failed, so the headline is a fail; T7 is published as the lead that the follow-up test went on to test, not as a validated edge.

Backtested by QS Research

Pre-registration

Written and amended on 2026-11-02, before any code or trade existed, and run once on a pinned snapshot of end-of-day option quotes. Four cells (30-60 and 300-450 days to expiry, at-the-money and 25-delta) were each tested at two thresholds, 1.0x and 0.9x the lower of one-year and three-month realized vol: eight counted trials, T1-T8. The signal is the tool's implied vol on the expiry's put-call-parity forward over that lower realized read, with same-day quotes only and a spread no wider than 25% of the mid. Each test buys a long call and a long put at the ask on the first trading day of every month, pays $0.0065 per share commission, holds to expiry and scores the return on premium. A test passes only if, at eight trials, the month-clustered bootstrap lower bound of signal minus the every-month baseline is above zero, every signal cell has baseline trades, the long-premium checks pass, and the difference is above zero on the 2022-2026 half alone; the 2016-2021 half is reported but not judged. One amendment before the run moved the implied-vol read from a spot Black-Scholes read to the tool's forward-based read and added the same-day quote and 25% spread filters.

Registered 2026-11-02

Amendments

The holdout was opened on 2026-11-02 (Read by the pre-registered pass rule in the counted run of 2026-11-02; the pre-registration set the 2022-2026 half as the judged holdout.).

Trials · 8 trials · 1 passed · judged at N = 8 trials; 2965 trials run in total

TrialVerdict
T1FAILcounted
T2FAILcounted
T3FAILcounted
T4FAILcounted
T5FAILcounted
T6FAILcounted
T7PASScounted
T8FAILcounted

Limitations

The numbers: every trial's checks, metrics, curve and yearly results, and the provenance

1 published version · current 9f1576c808cbd61f, published 2026-11-21

Put these signals to work

This page is free. Members get the live version of every QS Research signal. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans